161
Views
18
CrossRef citations to date
0
Altmetric
Original Investigations

Cognitive function in short- and long-term substitution treatment: Are there differences?

, MD, , &
Pages 400-408 | Received 24 Nov 2008, Accepted 15 Apr 2009, Published online: 10 Mar 2010

References

  • Aschenbrenner S, Tucha O, Lange KW. Regensburger Wortflüssigkeits-Test. Hogrefe, Göttingen 2000
  • Brooks DJ, Vosburg SK, Evans SM, Levin FR. Assessment of cognitive functioning of methadone-maintenance patients: Impact of adult ADHD and current cocaine dependence. J Addict Dis 2006; 25: 15–25
  • Buehringer G, Kroeger C, Kuefner H, Lieb R, Schuetz C, Soyka M, Wittchen H-U. Substance abuse research network ASAT: allocating substance abuse treatments to patient heterogeneity (in German). Suchtmed 2004; 6: 7–13
  • Curran HV, Kleckham J, Bearn J, Strang J, Wanigaratne S. Effects of methadone on cognition, mood and craving in detoxifying opioid addicts: a dose–response study. Psychopharmacology 2001; 154: 153–160
  • Darke S, Degenhardt L, Mattick R. Mortality amongst illicit drug users. Epidemiology, causes and intervention. Cambridge University Press, Cambridge 2007
  • Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among methadone maintenance patients. Addiction 2000; 95: 687–695
  • Davis PE, Liddiard H, McMillan TM. Neuropsychological deficits and opioid abuse. Drug Alcohol Depend 2002; 67: 105–108
  • Dittert S, Naber D, Soyka M. Methadone substitution and ability to drive. Results of an experimental study (in German). Nervenarzt 1999; 70: 457–462
  • Franke GH. SCL-90-R. The symptom check list from Derogatis – German version. Beltz, Göttingen 1995
  • Glass GV, Peckham PD, Sanders JR. Consequences of failure to meet assumptions underlying the fixed effects analysis of variance and covariance. Rev Educ Res 1972; 42: 237–288
  • Grevert P, Masover B, Goldstein A. Failure of methadone and levomethadyl acetate (levo-alpha-acetylmethadol, LAAM) maintenance to affect memory. Arch Gen Psychiatry 1977; 34: 849–853
  • Gruber SA, Tzilos GK, Silveri MM, Pollack M, Renshaw PF, Kaufman MJ, Yurgelun-Todd DA. Methadone maintenance improves cognitive performance after two months of treatment. Exp Clin Psychopharmacol 2006; 14: 157–164
  • Helmstaedter C, Lendt M, Lux S. Verbal Learning and Memory Test VLMT (in German). Hogrefe, Göttingen 2001
  • Klitzke MJ. The differential sensitivity of the Rey-Osterrieth Complex Figure and WAIS-R Block Design subtest in the assessment of constructional apraxia. Arch Clin Neuropsychol 1997; 12: 349
  • Kohler J, Beck U, Hohnecker B. Neuropsychological assessment of basic planning competence. J Int Neuropsychol Soc 2003; 9: 519
  • Lehrl, S. Multiple Choice Vocabulary Test MWT-B (in German). 2005. Balingen, Spitta
  • Lenné MG, Dietze P, Rumbold GR, Redman JR, Triggs TJ. The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on stimulated driving. Drug Alcohol Depend 2003; 72: 271–278
  • Lyvers M, Yakimoff M. Neuropsychological correlates of opioid dependence and withdrawal. Addict Behav 2003; 28: 605–611
  • Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev Issue 2003; 4, doi: 10.1002/14651858.CD002209
  • Meyers JE, Meyers KR. Rey complex figure test and recognition trial: Professional manual. Psychological Assessment Resources, Odessa, FL 1995
  • Mintzer MZ. Effects of opioid pharmacotherapy on psychomotor and cognitive performance: A review of human laboratory studies of methadone and burprenorphine. Her Addict Rel Clin Prob 2007; 9: 5–24
  • Mintzer MZ, Stitzer ML. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend 2002; 67: 41–51
  • Mintzer MZ, Copersino ML, Stitzer ML. Opioid abuse and cognitive performance. Drug Alcohol Depend 2005; 78: 225–230
  • Pirastu R, False R, Messina M, Binio V, Spiga S, Falconieri D, Diana M. Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies. Drug Alcohol Depend 2006; 83: 163–168
  • Prosser J, Cohen LJ, Steinfeld M, Eisenberg D, London ED, Galynker II. Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug Alcohol Depend 2006; 84: 240–247
  • Rapeli, P,Fabritius, C,Alho, H,Salaspuro, M,Wahlbeck, K,Kalska, H. 2007. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls. BMC Clin Pharmacol, 7:5, doi: 10.1186/1472-6904-7-5.
  • Reitan RM. Trail Making Test. Beltz, Weinheim 1979
  • Rey A. Lexamen clinique en psychologie. Presses Universitaires de France, Paris 1964
  • Rothenberg S, Schottenfeld S, Meyer RE, Krauss B, Gross K. Performance differences between addicts and non-addicts. Psychopharmacology 1977; 52: 299–306
  • Rotheram-Fuller E, Shoptaw S, Berman SM, London ED. Impaired performance in a test of decision-making by opiate-dependent tobacco smokers. Drug Alcohol Depend 2004; 73: 79–86
  • Sander W, Peters A, Schulz W. Using the SCL-90-R with alcohol-dependent patients to screen for comorbidity (in German). Sucht 2007; 53: 347–354
  • Schindler S-D, Ortner R, Peternell A, Eder H, Opgenoorth E, Fischer G. Maintenance therapy with synthetic opioids and driving aptitude. Eur Addict Res 2004; 10: 80–97
  • Shallice T. Specific impairments of planning. Phil Trans R Soc London 1982; 298: 199–209
  • Soyka M, Horak M, Dittert S, Kagerer S. Less driving impairment on buprenorphine than methadone in drug-dependent patients?. J Neuropsychiatry Clin Neurosci 2001; 13: 527–528
  • Soyka M, Hock B, Kagerer S, Lehnert R, Limmer C, Kuefner H. Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients. J Clin Psychopharmacol 2005; 25: 490–493
  • Soyka M, Apelt SM, Lieb M, Wittchen HU. One year mortality rates of patients receiving methadone and buprenorphine maintainance therapy: a nationally representatiive cohort study in 2694 patients. J Clin Psychopharmacol 2006; 26: 657–660
  • Soyka M, Zingg C, Koller G, Kuefner H. Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study. Int J Neuropsychopharmacol 2008a; 11: 641–653
  • Soyka M, Lieb M, Kagerer S, Zingg C, Koller G, Lehnert P, Limmer C, Kuefner H, Hennig-Fast K. Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial. J Clin Psychopharmacol 2008b; 28: 699–703
  • Tramullas M, Martinez-Cue C, Hurle MA. Chronic methadone treatment and repeated withdrawal impair cognition and increase the expression of apoptosis-related proteins in mouse brain. Psychopharmacology 2007; 193: 107–120
  • Verdejo A, Toribio I, Orozco C, Puente KL, Perez-Garcia M. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depend 2005; 78: 283–288
  • Wechsler D. Wechsler adult intelligence scale – revised. The Psychological Corporation, San Antonio, TX 1981
  • Wechsler D. Wechsler adult intelligence scale – III. The Psychological Corporation, San Antonio, TX 1997
  • Zacny JP. A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacol 1995; 3: 432–466
  • Zimmermann P, Fimm B. Test for Attentional Performance TAP (in German). PsyTest, Herzogenrath 1995

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.